E3 LIGASE WHOLE BODY ATLAS

Serial Number 90319084
606

Registration Progress

Application Filed
Nov 13, 2020
Under Examination
May 17, 2022
Approved for Publication
Mar 22, 2022
Published for Opposition
Mar 22, 2022
Registered

Trademark Image

E3 LIGASE WHOLE BODY ATLAS

Basic Information

Serial Number
90319084
Filing Date
November 13, 2020
Published for Opposition
March 22, 2022
Abandonment Date
June 17, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 17, 2024
Classes
042

Rights Holder

Kymera Therapeutics, Inc.

03
Address
200 Arsenal Yards Blvd., Suite 230
Watertown, MA 02472

Ownership History

Kymera Therapeutics, Inc.

Original Applicant
03
Watertown, MA

Kymera Therapeutics, Inc.

Owner at Publication
03
Watertown, MA

Legal Representation

Attorney
Glenn A. Gundersen

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

28 events
Date Code Type Description Documents
Jul 12, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 17, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Nov 21, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 17, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 17, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 17, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 12, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 10, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
May 10, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
May 10, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 16, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 14, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Nov 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 14, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 17, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 22, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 22, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 2, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 15, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 28, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 27, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 27, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 27, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Apr 27, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Apr 27, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Apr 22, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 17, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical research and development; drug development and discovery services; medical and scientific research; providing medical and scientific research information in the field of pharmaceuticals

Additional Information

Pseudo Mark
E THREE LIGASE WHOLE BODY ATLAS

Classification

International Classes
042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"E3 LIGASE"